Skip to main content
Advertisement
Advertisement
IMTX
IMTX logo
Immatics N.V. Ordinary Shares
6.36
USD
Sponsored
+0.18
+2.91%
Nov 06, 15:59 UTC -5
Closed
exchange

After-Market

6.36

0.00
0.00%

Immatics N.V. Ordinary Shares (IMTX) Profile

Immatics N.V. Ordinary Shares Profile

About

Immatics N.V. engages in the discovery of targets for cancer immunotherapies. It is developing targeted immunotherapies with focus on treating solid tumors. Immatics N.V., formerly known as ARYA SCIENCES, is based in Tuebingen, Germany.

Info & Links

CEO

Harpreet Singh

Headquarters

PAUL EHRLICH-STRASSE 15
TUBINGEN, 2M 72076, GERMANY

Sector

Medical

Auditor

PricewaterhouseCoopers GmbH

Share holders

32

Employees

407

Immatics N.V. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

968.15M

Enterprise Value

697.87M

Enterprise Value/EBITDA(ttm)

-2.79

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

19.85

Price to Book(mrq)

2.08

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-495.71%

Profit Margin(ttm)

-648.15%

Return on Equity(ttm)

-47.41%

Return on Invested Capital(ttm)

-48.00%

Return on Assets(ttm)

-39.45%

Income Statement

Revenue(ttm)

49.20M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

49.20M

EBITDA(ttm)3

-250.07M

Net Income Available to Common(ttm)

-240.74M

Diluted EPS(ttm)

-1.86

Share Statistics

Beta (5Y Monthly)

1.38

52-Week Change

-31.09%

S&P 500 52-Week Change

14.03%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

132.18M

% Held by Insiders

3.30%

% Held by Institutions

64.41%

Balance Sheet

Total Cash(mrq)

270.28M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.54%

Quick Ratio(mrq)

7.54%

Book Value Per Share(mrq)

3.40

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.87

Free Cash Flow(ytd)

-121.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement